BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35695096)

  • 1. Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome.
    Lyu X; Li T; Zhu D; Cheng Y; Chen Y; He X; Li Z; Li S; Wu W; Geng S; Zhang M; Yao C; Li J; Li Y; Chang Y; Li Y; Zhu Z; Mao M; Song Y
    Leuk Lymphoma; 2022 Oct; 63(10):2301-2310. PubMed ID: 35695096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
    Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
    Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shallow whole-genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics.
    Rengifo LY; Smits S; Boeckx N; Michaux L; Vandenberghe P; Dewaele B
    Genes Chromosomes Cancer; 2023 Nov; 62(11):663-671. PubMed ID: 37293982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
    Zhang R; Kim YM; Wang X; Li Y; Lu X; Sternenberger AR; Li S; Lee JY
    Int J Med Sci; 2015; 12(9):719-26. PubMed ID: 26392809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.
    Mareschal S; Palau A; Lindberg J; Ruminy P; Nilsson C; Bengtzén S; Engvall M; Eriksson A; Neddermeyer A; Marchand V; Jansson M; Björklund M; Jardin F; Rantalainen M; Lennartsson A; Cavelier L; Grönberg H; Lehmann S
    Blood Adv; 2021 Feb; 5(4):1003-1016. PubMed ID: 33591326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
    Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
    Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
    Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
    J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.
    Kolquist KA; Schultz RA; Furrow A; Brown TC; Han JY; Campbell LJ; Wall M; Slovak ML; Shaffer LG; Ballif BC
    Cancer Genet; 2011 Nov; 204(11):603-28. PubMed ID: 22200086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome.
    Kim YJ; Jung SH; Hur EH; Choi EJ; Lee KH; Park HC; Kim HJ; Kwon YR; Park S; Lee SH; Chung YJ; Lee JH
    Leuk Res; 2021 Apr; 103():106540. PubMed ID: 33667811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
    Duncavage EJ; Schroeder MC; O'Laughlin M; Wilson R; MacMillan S; Bohannon A; Kruchowski S; Garza J; Du F; Hughes AEO; Robinson J; Hughes E; Heath SE; Baty JD; Neidich J; Christopher MJ; Jacoby MA; Uy GL; Fulton RS; Miller CA; Payton JE; Link DC; Walter MJ; Westervelt P; DiPersio JF; Ley TJ; Spencer DH
    N Engl J Med; 2021 Mar; 384(10):924-935. PubMed ID: 33704937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
    Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
    Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.